32.28
Sensei Biotherapeutics Inc Azioni (SNSE) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-06-30 | 2024-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | - | - |
| Operating Expenses |
6.82%
4.851
|
5.206 | 7.274 | 7.787 | 8.73 |
| Interest Income/Expense |
40.00%
0.006
|
0.01 | 0.013 | 0.024 | 0.028 |
| Operating Income/Loss |
6.82%
-4.851
|
-5.206 | -7.274 | -7.787 | -8.73 |
| Income/Loss From Continuing Operations Before Tax |
7.44%
-4.569
|
-4.936 | -6.864 | -7.142 | -7.992 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
7.44%
-4.569
|
-4.936 | -6.864 | -7.142 | -7.992 |
|
|
7.44%
-4.569
|
-4.936 | -6.864 | -7.142 | -7.992 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.03%
1.2613
|
1.2609 | 25.19 | 25.10 | 25.05 |
| Diluted Average Shares |
0.03%
1.2613
|
1.2609 | 25.19 | 25.10 | 25.05 |
| Basic Earnings Per Share |
7.42%
-3.62
|
-3.91 | -0.27 | -0.28 | -0.32 |
| Diluted Earnings Per Share |
7.42%
-3.62
|
-3.91 | -0.27 | -0.28 | -0.32 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):